Jump to content

Imitrex Generics Expected

Recommended Posts

The US patent for Imitrex, sumatriptan succinate, expires in December 2006.

Ranbaxy Pharmaceuticals Ltd received tentative US FDA approval in August 2005 to market a generic sumatriptan succinate. Final approval is typically granted following patent expiration.

Reportedly, Mylan Laboratories has also received tentative approval to market as well.

Ranbaxy announcement: http://www.ranbaxy.com/newsroom/pressrelease_det.asp?sno=225

Yay for cheap migraine relieve!


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...